Michael Dechant
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Opioid substitution treatment, relapse and addiction-related outcomes in prison setting and after release: A longitudinal study.
Journal: Nordisk alkohol- & narkotikatidskrift : NAT
Published: October 24, 2023
Treatment of Opioid-dependent Inmates - Attitudes and Treatment Practice of medical Staff in Bavarian Prisons
Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: March 30, 2021
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.
Journal: British journal of haematology
Published: November 04, 2016
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2m(1) antibody.
Journal: mAbs
Published: February 05, 2014
Antibody-dependent cellular cytotoxicity in patients on chronic hemodialysis.
Journal: American journal of nephrology
Published: March 14, 2013
An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels.
Journal: British journal of haematology
Published: September 27, 2012
IgA EGFR antibodies mediate tumour killing in vivo.
Journal: EMBO molecular medicine
Published: August 23, 2012
Characterization of a mutated IgA2 antibody of the m(1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages.
Journal: The Journal of biological chemistry
Published: June 09, 2012
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expression.
Journal: Neoplasia (New York, N.Y.)
Published: November 23, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026